Search for Clinical Trial Results

Sponsored By

Phenylketonurias - 25 Studies Found

Status Study
Active, not recruiting Study Name: Kuvan® in Phenylketonuria Patients Less Than 4 Years Old
Condition: Phenylketonuria
Date: 2011-06-17
Interventions:
  • Drug: Kuvan® Kuvan®

Completed Study Name: The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)
Condition: Phenylketonuria
Date: 2009-05-01
Interventions:
  • Dietary Supplement: Docosahexaenoic Acid

Completed Study Name: Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
Condition: Phenylketonuria
Date: 2010-04-27
Interventions:
  • Drug: Sapropterin dihydrochloride

Completed Study Name: Low Phenylalanine Diet for Mothers With Phenylketonuria (PKU)
Condition: Phenylketonuria
Date: 2003-07-21
Interventions: Behavioral: Restricted phenylalanine diet
Completed Study Name: Response to Kuvan® in Subjects With Phenylketonuria (PKU) in a 4 Weeks Testing Period
Condition: Phenylketonuria
Date: 2010-03-05
Interventions: Drug: Kuvan® Kuvan® (sapropterin dihydrochloride) oral solution 20 milligram per kilogram (mg/
Completed Study Name: Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response
Condition: Phenylketonuria
Date: 2009-02-10
Interventions: Drug: Kuvan 20mg/kg/d, once daily Other Name: saprop
Completed Study Name: The Effects of Kuvan on Functional Brain Connectivity in Individuals With Phenylketonuria (PKU)
Condition: Phenylketonuria
Date: 2009-08-21
Interventions: Drug: Sapropterin Sapropterin (Kuvan) 20mg/kg/day taken once daily or as otherwise prescribed by physici
Completed Study Name: Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
Condition: Phenylketonuria
Date: 2008-03-06
Interventions: Drug: rAvPAL-PEG rAvPAL-PEG will be administered as a single, SC injection at dose levels of 0.001, 0.00
Completed Study Name: Study to Evaluate the Effects of Kuvan on Individuals With Phenylketonuria (PKU) With Maladaptive Behaviors
Condition: Phenylketonuria
Date: 2008-07-30
Completed Study Name: Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy
Condition: Phenylketonuria
Date: 2009-09-28
Interventions: Drug: Sapropterin All subjects will receive 20 mg/kg/day Sapropterin (KUVAN) for four months. Subjects w
<<< Previous | Next >>>